The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II trial of BMS-986205 and nivolumab as first line therapy in hepatocellular carcinoma.
 
Jasmine Huynh
No Relationships to Disclose
 
May Thet Cho
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Basilea; Eisai; Exelixis; Genentech/Roche; Ipsen; QED Therapeutics; Seagen; Taiho Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb/Celgene; Daiichi Sankyo/Astra Zeneca; Helsinn Therapeutics; natera; Pfizer; Taiho Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); incyte (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Arta Monir Monjazeb
Stock and Other Ownership Interests - Multiplexthera
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD Serono; Genentech; Incyte; Merck; Multiplexthera; Transgene; TriSalus Life Sciences
Research Funding - AstraZeneca; Bristol-Myers Squibb; EMD Serono; Genentech; Incyte; Merck; Transgene; TriSalus Life Sciences
 
Kit Wah Tam
No Relationships to Disclose
 
Amisha Singh
No Relationships to Disclose
 
Sima Naderi
No Relationships to Disclose
 
Ghaneh Fananapazir
No Relationships to Disclose
 
Ramit Lamba
No Relationships to Disclose
 
John McGahan
No Relationships to Disclose
 
Thomas W Loehfelm
No Relationships to Disclose
 
Shannon Navarro
No Relationships to Disclose
 
Susan L Stewart
No Relationships to Disclose
 
Frances Lara
No Relationships to Disclose
 
Anthony Martinez
No Relationships to Disclose
 
Leslie A Garcia
No Relationships to Disclose
 
Edward Jae-Hoon Kim
Consulting or Advisory Role - Eisai; Lilly; Taiho Oncology
Speakers' Bureau - Eisai
Research Funding - Astellas Pharma (Inst); BMS (Inst); Boston Biomedical (Inst); Celgene (Inst); Dynavax Technologies (Inst); EpicentRx (Inst); ERYTECH Pharma (Inst); Eureka Therapeutics (Inst); Fibrogen (Inst); Halozyme (Inst); Merck (Inst); NGM BIOPHARMACEUTICALS (Inst); OncoMed (Inst); Samumed (Inst)